P. Pemberton

455 total citations
11 papers, 363 citations indexed

About

P. Pemberton is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, P. Pemberton has authored 11 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Molecular Biology. Recurrent topics in P. Pemberton's work include Ovarian function and disorders (3 papers), Reproductive Biology and Fertility (3 papers) and Peptidase Inhibition and Analysis (2 papers). P. Pemberton is often cited by papers focused on Ovarian function and disorders (3 papers), Reproductive Biology and Fertility (3 papers) and Peptidase Inhibition and Analysis (2 papers). P. Pemberton collaborates with scholars based in United Kingdom and United States. P. Pemberton's co-authors include Alwyn Smith, S. A. Roberts, Allen P. Yates, Oybek Rustamov, Luciano G. Nardo, Cheryl Fitzgerald, M. Krishnan, Sarah Kitson, Henry C Kitchener and Emma J. Crosbie and has published in prestigious journals such as British Journal of Cancer, Human Reproduction and Biochemical Society Transactions.

In The Last Decade

P. Pemberton

11 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Pemberton United Kingdom 6 255 213 82 72 42 11 363
Shiuh Young Chang Taiwan 12 226 0.9× 167 0.8× 101 1.2× 111 1.5× 16 0.4× 22 379
D. W. Cramer United States 4 224 0.9× 187 0.9× 40 0.5× 50 0.7× 33 0.8× 5 376
F. Fischl Austria 10 277 1.1× 292 1.4× 60 0.7× 102 1.4× 65 1.5× 26 449
Benjamin P. Christian United States 5 432 1.7× 401 1.9× 81 1.0× 96 1.3× 18 0.4× 6 537
Zeina Haoula United Kingdom 9 328 1.3× 218 1.0× 79 1.0× 45 0.6× 19 0.5× 14 414
Pam Mamers Australia 10 155 0.6× 83 0.4× 121 1.5× 24 0.3× 35 0.8× 13 319
Dean M. Moutos United States 10 167 0.7× 160 0.8× 64 0.8× 66 0.9× 29 0.7× 18 378
San‐Nung Chen Taiwan 12 161 0.6× 180 0.8× 121 1.5× 113 1.6× 26 0.6× 29 431
J. Callejo Spain 8 229 0.9× 202 0.9× 37 0.5× 36 0.5× 14 0.3× 16 344
Olga Triantafyllidou Greece 12 212 0.8× 134 0.6× 56 0.7× 53 0.7× 36 0.9× 36 365

Countries citing papers authored by P. Pemberton

Since Specialization
Citations

This map shows the geographic impact of P. Pemberton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Pemberton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Pemberton more than expected).

Fields of papers citing papers by P. Pemberton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Pemberton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Pemberton. The network helps show where P. Pemberton may publish in the future.

Co-authorship network of co-authors of P. Pemberton

This figure shows the co-authorship network connecting the top 25 collaborators of P. Pemberton. A scholar is included among the top collaborators of P. Pemberton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Pemberton. P. Pemberton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Sivalingam, Vanitha N., Sarah Kitson, Rhona J. McVey, et al.. (2016). Measuring the biological effect of presurgical metformin treatment in endometrial cancer. British Journal of Cancer. 114(3). 281–289. 72 indexed citations
3.
Rustamov, Oybek, Alwyn Smith, S. A. Roberts, et al.. (2012). Anti-Mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Human Reproduction. 27(10). 3085–3091. 136 indexed citations
4.
Rustamov, Oybek, Alwyn Smith, S. A. Roberts, et al.. (2012). Reply: reproducibility of AMH. Human Reproduction. 27(12). 3641–3642. 2 indexed citations
5.
Yates, Allen P., Oybek Rustamov, Stephen A. Roberts, et al.. (2011). Anti Mullerian hormone-tailored protocols improve outcomes, reduce adverse effects and costs of IVF. Human Reproduction. 1 indexed citations
6.
Yates, Allen P., Oybek Rustamov, S. A. Roberts, et al.. (2011). Anti-Mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF. Human Reproduction. 26(9). 2353–2362. 108 indexed citations
7.
Pemberton, P., et al.. (1997). An aminopeptidase N deficiency in dog small intestine. Research in Veterinary Science. 63(2). 133–138. 3 indexed citations
8.
Pemberton, P., et al.. (1997). Gluten-sensitive enteropathy in Irish setter dogs: characterisation of jejunal microvillar membrane proteins by two-dimensional electrophoresis. Research in Veterinary Science. 62(2). 191–193. 3 indexed citations
9.
Gleeson, Dermot, et al.. (1994). Acid‐base transport systems in a polarized human intestinal cell monolayer: Caco‐2. Experimental Physiology. 79(5). 723–739. 13 indexed citations
10.
Flint, Neil, et al.. (1994). Cytokeratin expression in epithelial cells isolated from the crypt and villus regions of the rodent small intestine.. PubMed. 3(1). 16–23. 14 indexed citations
11.
Pemberton, P., et al.. (1985). Hydrolysis of benzoyl-tyrosyl-p-aminobenzoic acid by a human intestinal microvillar peptidase. Biochemical Society Transactions. 13(1). 175–176. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026